Drugs by condition
Drugs approved for endometrial cancer
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
9
Still marketed, NDA or BLA
Drug classes
7
Novel drugs
7
New molecular entities and new biologics
In development
40+
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for endometrial cancer.
- Keytruda Qlex (Pembrolizumab, Berahyaluronidase Alfa-Pmph) · Merck Sharp Dohme NovelAccelerated approvalPriority reviewSep 19, 2025
- Jemperli (Dostarlimab-Gxly) · Glaxosmithkline NovelBreakthrough therapyAccelerated approvalPriority reviewApr 22, 2021
- Imfinzi (Durvalumab) · Astrazeneca Uk LTD NovelBreakthrough therapyAccelerated approvalPriority reviewOrphanMay 1, 2017
- Lenvima (Lenvatinib Mesylate) · Eisai INC NovelBreakthrough therapyAccelerated approvalPriority reviewOrphanFeb 13, 2015
- Keytruda (Pembrolizumab) · Merck Sharp Dohme NovelBreakthrough therapyAccelerated approvalPriority reviewOrphanSep 4, 2014
All approved drugs for endometrial cancer, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 19 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Programmed Death Receptor-1 Blocking Antibody (2)
Endoglycosidase (1)
- Keytruda Qlex Pembrolizumab, Berahyaluronidase Alfa-Pmph · Merck Sharp Dohme · 2025
Programmed Death Ligand-1 Blocker (1)
- Imfinzi Durvalumab · Astrazeneca Uk LTD · 2017
Kinase Inhibitor (1)
- Lenvima Lenvatinib Mesylate · Eisai INC · 2015
Gonadotropin (1)
- Ovidrel Choriogonadotropin Alfa · Emd Serono · 2000
Progesterone (1)
- Prometrium Progesterone · Acertis Pharms · 1998
Class not listed in FDA's data (2)
Drugs in development for endometrial cancer
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- SKB264MK-2870, Sacituzumab TirumotecanPhase 353 trials
Merck & Co. · Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Cervical Cancer
- RilvegostomigAZD2936Phase 325 trials
AstraZeneca · Biliary Tract Cancer, Gastric Cancer, Non-small Cell Lung Cancer
- SintilimabIBI308Phase 321 trials
Innovent Biologics (Suzhou) Co. Ltd. · Hepatocellular Carcinoma, Solid Tumor, HCC - Hepatocellular Carcinoma
- VolrustomigMEDI5752Phase 313 trials
AstraZeneca · Gastric Cancer, Non-small Cell Lung Cancer, Biliary Tract Cancer
- Anlotinib hydrochlorideAL3818, CatequentenibPhase 312 trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Alveolar Soft Part Sarcoma, Metastatic Colorectal Cancer, Endometrial Neoplasms
- SaruparibAZD5305Phase 310 trials
AstraZeneca · Prostate Cancer, Ovarian Cancer, Endometrial Cancer
- FavezelimabMK-4280, MK-4820APhase 39 trials
Merck & Co. · Melanoma, Carcinoma, Renal Cell, Solid Tumors
- Rina-SPRO1184, GEN1184Phase 39 trials
Genmab · Ovarian Cancer, Platinum-resistant Ovarian Cancer, Endometrial Cancer
- Mocertatug rezetecanMo-RezPhase 36 trials
GSK · Ovarian Neoplasms, Neoplasms, Endometrial, Tumours, Gynecological
- OlomorasibLY3537982Phase 36 trials
Eli Lilly · Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Neoplasm Metastasis
- DB-1303BNT323, trastuzumab pamirtecanPhase 35 trials
DualityBio Inc. · Metastatic Breast Cancer, HER2-positive Advanced Solid Tumor, Endometrial Cancer
- AL8326Phase 34 trials
Advenchen Pharmaceuticals, LLC. · Endometrial Neoplasms, Soft Tissue Sarcoma (STS), Breast Neoplasms
- AZD5335Torvutatug samrotecan, Torvu-samPhase 34 trials
AstraZeneca · Epithelial Ovarian Cancer, Ovarian Cancer, Lung Adenocarcinoma
- HB0025Phase 34 trials
Shanghai Huaota Biopharmaceutical Co., Ltd. · First-line pMMR Endometrial Cancer, Non Squamous Non-small Cell Lung Cancer, TNBC
- KRT-232NavtemadlinPhase 34 trials
Kartos Therapeutics, Inc. · Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma
- HS-20089Phase 33 trials
Hansoh BioMedical R&D Company · Ovarian Cancer, Platinum-sensitive Recurrent Ovarian Cancer, Fallopian Tube Cancer
- EG-007Phase 32 trials
Evergreen Therapeutics, Inc. · Advanced Endometrial Cancer
- TQB2450Phase 32 trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Endometrial Cancer, Non Small Cell Lung Cancer
- TR115Phase 32 trials
Tarapeutics Science Inc. · Ovarian Clear Cell Carcinoma, Endometrial Cancer, Stomach Cancer Recurrent
- Olaparib phasePhase 31 trial
AstraZeneca · Advanced or Recurrent Endometrial Cancer
More on endometrial cancer: recruiting trials · published research
Related in oncology: Breast cancer · Non-small cell lung cancer · Small cell lung cancer · Prostate cancer · Colorectal cancer · Melanoma · Ovarian cancer · Pancreatic cancer · Bladder and urothelial cancer · Kidney cancer (renal cell carcinoma)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.